Stress degradation studies of nelfinavir mesylate by Fourier transform infrared spectroscopy

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 3, 2010, Pages 287-294

  Singh, Parul ^a   Mehrotra, Ranjana ^a   Bakhshi, A K ^b  

^a NATIONAL PHYSICAL LABORATORY   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Fourier transform infrared spectroscopy; HIV protease inhibitors; ICH; Nelfinavir mesylate; Stress degradation

Indexed keywords

ACID; BASE; NELFINAVIR;

ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EXPOSURE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INFRARED SPECTROSCOPY; OXIDATION; OXIDATIVE STRESS; PHOTODEGRADATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION; SUNLIGHT; THERMAL ANALYSIS; THERMOGRAVIMETRY; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; HIV PROTEASE INHIBITORS; NELFINAVIR; PHOTOLYSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMOGRAVIMETRY; X-RAY DIFFRACTION;

EID: 77954860080     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.03.030     Document Type: Article

References (29)

1. Stein J.H. Dyslipidemia in the era of HIV protease inhibitors. Prog. Cardiovasc. Dis. 2003, 45:293-304.
2. Yamada H., Kotaki H., Nakamura T., Iwamoto A. Simultaneous determination of HIV protease inhibitors indinavir, amprinavir, saquinavir, ritonavir and nelfinavir in human plasma by high performance liquid chromatography. J. Chromatogr. B 2001, 755:85-89.
3. Turner M.L., Reed-Walker K., King J.R., Acosta E.P. Simultaneous determination of nine antiretroviral compounds in human plasma using liquid chromatography. J. Chromatogr. B 2003, 784:331-341.
4. Marzolini C., Telenti A., Buclin T., Biollaz J. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction. J. Chromatogr. B 2000, 740:43-58.
5. Sarasa-Nacenta M., Lopez-Pua Y., Mallolas J., Blanco J.L. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography. J. Chromatogr. B 2001, 757:325-332.
6. Dailly E., Thomas L., Kergueris M.F., Jolliet P., Bourin M. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction. J. Chromatogr. B 2001, 758:129-135.
7. Justesen U.S., Pedersen C., Klitgaard N.A. Simultaneous quantitative determination of the HIV protease inhibitors indinavir, amprinavir, ritonavir, lopinavir, saquinavir, nelfinavir and nelfinavir active metabolite M8 in plasma by liquid chromatography. J. Chromatogr. B 2003, 783:491-500.
8. Rentsch K.M. Sensitive and specific determination of eight antiretroviral agents in plasma by high performance liquid chromatography mass spectrometry. J. Chromatogr. B 2003, 788:339-350.
9. van Heeswijk R.P.G., Hoetelmans R.M.W., Harms R., Meenhorst P.L., Mulder J.W., Lange J.M.A., Beijnen J.H. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. B 1998, 719:159-168.
10. Chi J., Jayewardene A.L., Stone J.A., Motoya T., Aweeka F.T. Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS. J. Pharm. Biomed. Anal. 2002, 30:675-684.
11. Janoly A., Bleyzac N., Favetta P., Gagneu M.C., Bourhis Y., Coudray S., Oger I., Aulagner G. Simple and rapid high performance liquid chromatographic method for nelfinavir, M8 nelfinavir metabolite, ritonavir and saquinavir assay in plasma. J. Chromatogr. B 2002, 780:155-160.
12. Kaul N., Agrawal H., Paradkar A.R., Mahadik K.R. Stability indicating high-performance thin-layer chromatographic determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form. Anal. Chim. Acta 2004, 502:31-38.
13. Jing Q., Shen Y., Tang Y., Ren F., Yu X., Hou Z. Determination of nelfinavir mesylate as bulk drug and in pharmaceutical dosage form by stability indicating HPLC. J. Pharm. Biomed. Anal. 2006, 41:1065-1069.
14. Rao S., Reddy T.R.S., Prasad U.V., Sastry C.S.P. Assay of nelfinavir mesylate in pharmaceutical formulations by visible spectrophotometry. Asian J. Chem. 2003, 15:971-976.
15. Rao S., Reddy T.R.S., Rao I.N., Sastry C.S.P. Spectrophotometric methods for the determination of nelfinavir mesylate. J. Anal. Chem. 2004, 59:552-556.
16. Sankar D.G., Reddy M., Kumar J.M.R., Murthy T.K. UV spectrophotometric determination of some anti-HIV drugs. Asian J. Chem. 2002, 14:433-436.
17. International Pharmacopoeia 2006, World Health Organization, Geneva, Switzerland, p. 653. 4th ed.
18. Yekkala R.S., Vandenwayenberg S., Hoogmartens J., Adams E. Evaluation of an international pharmacopoeia method for the analysis of nelfinavir mesylate by liquid chromatography. J. Chromatogr. A 2006, 1134:56-65.
19. Prakash K.V., Venkateswara Rao J., Appala Raju N. RP-HPLC method for the estimation of nelfinavir mesylate in tablet dosage form. E-J. Chem. 2007, 4:302-306.
20. Seshachalam U., Rajababu B., Haribabu B., Chandrasekhar K.B. Novel stability-indicating RP-LC method for the determination of nelfinavir mesylate and its related impurities in drug substance and pharmaceutical formulations. J. Liquid Chromatogr. Relat. Technol. 2008, 31:395-409.
21. Teraoka R., Akoto Otsuka M., Matsuda Y. Evaluation of photostability of solid state nicardipine hydrochloride polymorphs by using Fourier transformed reflection absorption infrared spectroscopy-effect of grinding on the photostability of crystal forms. Int. J. Pharm. 2004, 286:1-8.
22. Matsuda Y., Akazawa R., Teraoka R., Otsuka M. Pharmaceutical evaluation of carbamazepine modifications: comparative stability for photostability of carbamazepine polymorphs by using Fourier-transformed reflection absorption infrared spectroscopy and calorimetric measurement. J. Pharm. Pharmacol. 1994, 46:162-167.
23. Teraoka R., Matsuda M., Matsuda Y. Evaluation of photostability of solid-state dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitro-phenyl)-3,5-pyridinedicarboxylate by using Fourier-transformed reflection-absorption infrared spectroscopy. Int. J. Pharm. 1999, 184:35-43.
24. Markovic N., Agotonovic-Kustrin S., Glass B., Prestidge C.A. Physical and thermal characterization of chiral omeprazole sodium salts. J. Pharm. Biomed. Anal. 2006, 42:25-31.
25. Singh P., Premkumar L., Mehrotra R., Kandpal H.C., Bakhshi A.K. Evaluation of thermal stability of indinavir sulphate using diffuse reflectance infrared spectroscopy. J. Pharm. Biomed. Anal. 2008, 47:248-254.
26. Singh P., Tyagi G., Mehrotra R., Bakhshi A.K. Thermal stability studies of 5-fluorouracil using diffuse reflectance infrared spectroscopy. Drug Test. Anal. 2009, 1:240-244.
27. Masmoudi H., Le Dream Y., Piecerelle P., Kister J. The evaluation of cosmetic and pharmaceutical emulsions aging process using classical techniques and a new method FTIR. Int. J. Pharm. 2005, 289:117-131.
28. Franzke D., Kritzenberger J., Ortelli E.E., Baindl A., Nuyken O., Wokaun A. Photolysis and thermolysis of diaryl (pentazadiene) compounds in solid matrix investigated by infrared spectroscopy. J. Photochem. Photobiol. A: Chem. 1998, 112:63-72.
29. George Socrates Infrared Characteristic Group Frequencies 1994, John Wiley & Sons, England. 2nd ed.